Clinical trial
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
NCT06666283
Study timeline
Study start (actual)2025-02-27Date precision: day
Registry last updated2025-09-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Kidney Diseaseunresolved
Interventions
AP303 150μgDRUG
Placebo 150μgDRUG
Sponsors & collaborators
Alebund Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06666283 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.